The C-peptide correlations and effect on the glycemic variability parameters in patients with type 2 diabetes.
Background and aims:Glycemic variability is an important aspect of glycemic control -linked to the development of diabetes chronic complications. Endogenous insulin secretion varies widely among patients with type 2 diabetes (T2DM) and might be an important factor involved in the control of glycemic variability. Material and method:We included data from 53 patients with T2DM and complete continuous glucose monitoring (CGM) recording (first 24 hours of recording starting from the midnight after insertion with no pause in recorded values). Endogenous insulin secretion was assessed by C-peptide levels. We collected from patients’ medical charts data on age, gender, anthropometric parameters – weight, height, body mass index (BMI), visceral fat area (VFA) and percent of body fat (PBF), diabetes duration and treatment, HbA1c and C-peptide levels. The following glycemic variability parameters were calculated:mean level of 24h interstitial glucose value (MG);median glucose value (MedG);standard deviation (SD);percentage coefficient of variation (%CV);weighted average of glucose values around 100 mg/dl (M100);J index;percentage of glucose values above 180 mg/dl (%above180) or below 70 mg/dl and 54 mg/dl (%below70 and %below54);mean amplitude of glycemic excursion (MAGE);fractal dimension (FD);continuous overall net glycemic action (CONGA) at 1, 2, 4 and 6 hours. Results:Mean age of patients included in the analysis was 55.6±8.96 years and median duration of diabetes 4 years (0;9.75 years). Median C-peptide value was 2.71 ng/ml (1.91;3.89) and mean HbA1c was 8.29±1.90%. C-peptide quartile correlated significantly with body weight (r=0.520, p < 0.001), BMI (r=0.481, p < 0.001), VFA (r=0.338, p=0.013), M100 (r=-0.294;p=0.032), J index (r=-0.271;p=0.050), % above126 (r=-0.275;p=0.046), CONGA-1 (r=-0.332, p=0.015) and CONGA-2 (r=-0.298, p=0.030). Patients in the lowest C-peptide quartile had significantly higher values of mean glucose levels (180.69 mg/dl vs. 141.37 mg/dl, p=0.017), J index (50.50 vs. 30.77, p=0.020), % above126 (93.73% vs. 59.03%, p=0.013) and % above180 (49.65% vs. 15.97%, p=0.026) and significantly lower weight (79.2 kg vs.101.8 kg, p=0.004), BMI (28.2 kg/m2 vs. 34.8 kg/m2, p=0.002) and VFA (133.9 cm2 vs. 155.00 cm2, p=0.048) than patients in highest quartile. Conclusions:Endogenous insulin secretion was correlated with weight, BMI, VFA and better glycemic control, expressed as HbA1c value or time spent in hyperglycemia, and few other glycemic variability parameters evaluated by CGMS.
